Half-year report · HY
4021.TEDINET S100X0X9
Period2025-04-01 → 2025-09-30
Filed2025-11-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥130.1bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥251.4bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥118.2bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥29.6bn | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥28.3bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥29.8bn | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥58.0bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥27.9bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥29.8bn | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥28.8bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥22.8bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥43.0bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥20.5bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥23.2bn | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥20.2bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥322.2bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥330.8bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥311.4bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥80.9bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥94.6bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥241.4bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥236.2bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥231.6bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥34.3bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥27.5bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥34.3bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥27.5bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥30.4bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥22.7bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥48.7bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥59.2bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥46.2bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥8.1bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥17.6bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥7.0bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥35.0bn | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥35.6bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥31.1bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥168.45 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥313.26 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥148.78 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 73.9% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.5% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.4% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 64
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2025-04-01 → 2025-09-30 | ¥14.8bn |
| Otherother segments | revenue external | 2025-04-01 → 2025-09-30 | ¥6.8bn |
| Otherother segments | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥8.0bn |
| Otherother segments | segment profit | 2025-04-01 → 2025-09-30 | ¥789m |
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2025-09-30 | −¥61.9bn |
| Reconciling Itemsreconciling | revenue external | 2025-04-01 → 2025-09-30 | −¥12.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2025-09-30 | −¥49.4bn |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2025-09-30 | −¥3.1bn |
| Agricultural Chemical Productsreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥42.3bn |
| Agricultural Chemical Productsreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥36.7bn |
| Agricultural Chemical Productsreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥5.6bn |
| Agricultural Chemical Productsreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥12.0bn |
| Chemical Productsreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥18.8bn |
| Chemical Productsreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥12.5bn |
| Chemical Productsreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥6.4bn |
| Chemical Productsreportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥97m |
| Functional Materialsreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥54.4bn |
| Functional Materialsreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥39.4bn |
| Functional Materialsreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥15.0bn |
| Functional Materialsreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥17.4bn |
| Healthcarereportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥2.8bn |
| Healthcarereportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥2.8bn |
| Healthcarereportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥48m |
| Healthcarereportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥695m |
| Wholesalereportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥58.8bn |
| Wholesalereportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥44.4bn |
| Wholesalereportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥14.4bn |
| Wholesalereportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2025-09-30 | ¥192.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2025-09-30 | ¥142.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥49.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2025-09-30 | ¥32.7bn |
| Otherother segments | revenue | 2024-04-01 → 2024-09-30 | ¥12.0bn |
| Otherother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥4.5bn |
| Otherother segments | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥7.5bn |
| Otherother segments | segment profit | 2024-04-01 → 2024-09-30 | ¥34m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥59.1bn |
| Reconciling Itemsreconciling | revenue external | 2024-04-01 → 2024-09-30 | −¥12.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥46.6bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥3.6bn |
| Agricultural Chemical Productsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥39.2bn |
| Agricultural Chemical Productsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥32.1bn |
| Agricultural Chemical Productsreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥7.0bn |
| Agricultural Chemical Productsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥14.4bn |
| Chemical Productsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥17.9bn |
| Chemical Productsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥11.8bn |
| Chemical Productsreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥6.0bn |
| Chemical Productsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | −¥292m |
| Functional Materialsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥48.6bn |
| Functional Materialsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥36.0bn |
| Functional Materialsreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥12.6bn |
| Functional Materialsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥14.5bn |
| Healthcarereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥3.3bn |
| Healthcarereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥3.2bn |
| Healthcarereportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥74m |
| Healthcarereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥1.3bn |
| Wholesalereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥56.3bn |
| Wholesalereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥43.0bn |
| Wholesalereportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥13.3bn |
| Wholesalereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥2.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥177.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥130.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥46.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥32.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 576
| Item | Context | Value | Unit |
|---|---|---|---|
| Note on independent audit financial information | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated balance sheet (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of income (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of comprehensive income (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of cash flows (text) | InterimDuration | Text · Plus | |
| Notes changes in scope of consolidation or equity method (text) | InterimDuration | Text · Plus | |
| Notes additional information semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Notes regarding guarantee obligations (text) | InterimInstant | Text · Plus | |
| Creditors notes regarding overdraft contracts and or loan commitments (text) | InterimInstant | Text · Plus | |
| Major components of selling general and administrative expenses (text) | InterimDuration | Text · Plus | |
| Notes regarding receipts from contingent consideration (text) | InterimDuration | Text · Plus | |
| Notes regarding income taxes for global minimum tax notes type1 semi annual consolidated statement of income (text) | InterimDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | InterimDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1InterimDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | Prior1InterimDuration | Text · Plus | |
| Notes regarding dividend (text) | InterimDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | InterimDuration | Text · Plus | |
| Notes segment information etc type1 semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1InterimDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | InterimDuration | Text · Plus | |
| Disclosure of changes etc in reportable segments (text) | InterimDuration | Text · Plus | |
| Notes revenue recognition semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Notes per share information semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Notes significant events after reporting period semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | InterimDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |